-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Upgrades Merck & Co to Overweight, Raises Price Target to $179

Benzinga·08/20/2026 10:07:07
語音播報
Morgan Stanley analyst Terence Flynn upgrades Merck & Co (NYSE:MRK) from Equal-Weight to Overweight and raises the price target from $116 to $179.